Advertisement

Index by author

June 01, 1996; Volume 49,Issue 6

A

  1. Ali-Osman, F

    1. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

  2. Antoun, G

    1. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

B

  1. Bahouth, S W

    1. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;

  2. Basolo, F

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

  3. Baur, R

    1. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;

  4. Bhama, J K

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  5. Blakely, R D

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  6. Boulanger, Y

    1. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;

  7. Buhr, A

    1. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;

C

  1. Chao, J

    1. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

  2. Chaudhary, A

    1. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
      D J Snyders and A Chaudhary
      Molecular Pharmacology June 1996, 49 (6) 949-955;

  3. Chiba, P

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  4. Chik, C L

    1. Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;

  5. Cobb, R R

    1. D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;

  6. Cohen, S M

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  7. Cole, S P

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

  8. Coon, M J

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  9. Coronel, E C

    1. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;

  10. Coutsogeorgopoulos, C

    1. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

D

  1. Danesi, R

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

  2. Deeley, R G

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

  3. Del Tacca, M

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

  4. Ding, X

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  5. Domin, B

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  6. Drach, J

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

E

  1. Ecker, G

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  2. Eling, T E

    1. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

F

  1. Fain, J N

    1. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;

  2. Felts, K A

    1. D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;

  3. Fernandez-Salguero, P

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  4. Forget, M A

    1. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;

  5. Fournier, A

    1. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;

  6. Fremeau, R T

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  7. Fukuchi, J

    1. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

G

  1. Gagucas, E

    1. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

  2. Gekeler, V

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  3. Gerlach, J H

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

  4. Gershengorn, M C

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  5. Girvin, M E

    1. Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;

  6. Glasgow, W C

    1. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

  7. Gokmen-Polar, Y

    1. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;

  8. Goldenberg, S

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  9. Gonzalez, F J

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  10. Guarnieri, F

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

H

  1. Henzi, V A

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  2. Hill, E M

    1. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

  3. Ho, A K

    1. Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;

  4. Hockerman, G H

    1. Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;

  5. Holý, A

    1. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

I

  1. Igarashi, K

    1. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

  2. Irons, R D

    1. Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;

J

  1. Jakobs, K H

    1. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;

  2. Jeong, K S

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

K

  1. Kallarakal, A T

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  2. Kallia-Raftopoulos, S

    1. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

  3. Kashiwagi, K

    1. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

  4. Kramata, P

    1. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

L

  1. Laakkonen, L

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  2. Laser, K T

    1. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;

  3. Lebel, N

    1. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;

  4. Lee, I J

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  5. Li, W

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  6. Liu, P C

    1. Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;

M

  1. Mackman, N

    1. D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;

  2. Malbon, C C

    1. Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;

  3. Malherbe, P

    1. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;

  4. Matsumura, F

    1. Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;

  5. McGown, S R

    1. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

  6. Meyer Zu Heringdorf, D

    1. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;

  7. Miller, J W

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  8. Miras-Portugal, M T

    1. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;

  9. Moeller, K D

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  10. Myers, C E

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

N

  1. Nadler, J V

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  2. Nardini, D

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

O

  1. Ogiwara, T

    1. Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;

  2. Osman, R

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  3. Otová, B

    1. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

  4. Ottenheijm, H C

    1. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

P

  1. Parry, G C

    1. D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;

  2. Perlman, J H

    1. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

  3. Phillips, M A

    1. Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;

  4. Pyatt, D W

    1. Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;

R

  1. Rajagopal, S

    1. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

  2. Roberts, B J

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  3. Rodriguez-Pascual, F

    1. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;

  4. Ruoho, A E

    1. Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;

S

  1. Samid, D

    1. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

  2. Schmid, D

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  3. Shafqat, S

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  4. Sheng, J J

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  5. Sigel, E

    1. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;

  6. Sirois, P

    1. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;

  7. Snyders, D J

    1. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
      D J Snyders and A Chaudhary
      Molecular Pharmacology June 1996, 49 (6) 949-955;

  8. Song, B J

    1. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

  9. Spink, D C

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  10. Stillman, W S

    1. Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;

  11. Stride, B D

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

  12. Synetos, D

    1. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

T

  1. Tell, B

    1. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

  2. Tomer, K B

    1. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

  3. Torres, M

    1. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;

V

  1. Valdimarsson, G

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

  2. van den Broek, L A

    1. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

  3. Van Koppen, C J

    1. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;

  4. Vaz, A D

    1. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;

  5. Velaz-Faircloth, M

    1. A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;

  6. Votruba, I

    1. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

W

  1. Wang, H

    1. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

  2. Williams, K

    1. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

  3. Wilson, G M

    1. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

Z

  1. Zhang, C

    1. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
Back to top

In this issue

Advertisement